Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Microfluidic systems to examine Müller glia responses to anti-VEGF treatments

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Fig. 1: Müller glia in vivo and in vitro.

References

  1. 1.

    National Eye Institute. Diabetic retinopathy data and statistics. United States; 2020. Available from: https://www.nei.nih.gov/learn-about-eye-health/resources-for-health-educators/eye-health-data-and-statistics/diabetic-retinopathy-data-and-statistics.

  2. 2.

    National Eye Institute. Age-related macular degeneration (AMD) data and statistics. United States; 2019. Available from: https://www.nei.nih.gov/learn-about-eye-health/resources-for-health-educators/eye-health-data-and-statistics/age-related-macular-degeneration-amd-data-and-statistics.

  3. 3.

    National Eye Institute. Glaucoma data and statistics. United States; 2019. Available from: https://www.nei.nih.gov/learn-about-eye-health/resources-for-health-educators/eye-health-data-andstatistics/glaucoma-data-and-statistics.

  4. 4.

    Royal National Institute of Blind People. Key information and statistics on sight loss in the UK > Sight Loss Data Tool. United Kingdom; 2020. Available from: https://www.rnib.org.uk/professionals/knowledge-and-research-hub/key-information-and-statistics/sight-loss-data-tool.

  5. 5.

    Mathur R, Douglas I, Bhaskaran K, Smeeth L. Diabetic eye disease: a UK Incidence and Prevalence Study. Royal United Kingdom: National Institute of Blind People; 2017. Available from: https://www.rnib.org.uk/sites/default/files/Diabetic%20eye%20disease.%20A%20UK%20Incidence%20and%20Prevalence%20Study%20-%20Full%20report.pdf.

  6. 6.

    Rofagha S, Bhisitkul RB, Boyer DS, Sadda SR, Zhang K. Group S-US seven-year outcomes in ranibizumab-treated patients in ANCHOR, MARINA, and HORIZON: a multicenter cohort study (SEVEN-UP). Ophthalmology. 2013;120:2292–9.

    Article  Google Scholar 

  7. 7.

    Cheema MR, DaCosta J, Talks J. Ten-year real-world outcomes of anti-vascular endothelial growth factor therapy in neovascular age-related macular degeneration. Clin Ophthalmol. 2021;15:279–87.

    Article  Google Scholar 

  8. 8.

    Daniel E, Toth CA, Grunwald JE, Jaffe GJ, Martin DF, Fine SL, et al. Risk of scar in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2014;121:656–66.

    Article  Google Scholar 

  9. 9.

    Daniel E, Pan W, Ying GS, Kim BJ, Grunwald JE, Ferris FL 3rd, et al. Development and course of scars in the comparison of age-related macular degeneration treatments trials. Ophthalmology. 2018;125:1037–46.

    Article  Google Scholar 

  10. 10.

    Vazquez M. Microfluidic and microscale assays to examine regenerative strategies in the neuro retina. Micromachines. 2020;11:1089.

    Article  Google Scholar 

  11. 11.

    Tiwari SK, Bhat S, Mahato KK. Design and fabrication of low-cost microfluidic channel for biomedical application. Sci Rep. 2020;10:9215.

    CAS  Article  Google Scholar 

  12. 12.

    Achberger K, Probst C, Haderspeck J, Bolz S, Rogal J, Chuchuy J, et al. Merging organoid and organ-on-a-chip technology to generate complex multi-layer tissue models in a human retina-on-a-chip platform. Elife. 2019;8:e46188.

    Article  Google Scholar 

  13. 13.

    Pena JS, Vazquez M. VEGF upregulates EGFR expression to stimulate chemotactic behaviors in the rMC-1 model of Muller glia. Brain Sci. 2020;10:330.

    CAS  Article  Google Scholar 

  14. 14.

    Pena JS, Robles D, Zhang S, Vazquez M. A milled microdevice to advance glia-mediated therapies in the adult nervous system. Micromachines. 2019;10:513.

    Article  Google Scholar 

  15. 15.

    Shen W, Yau B, Lee SR, Zhu L, Yam M, Gillies MC. Effects of ranibizumab and aflibercept on human muller cells and photoreceptors under stress conditions. Int J Mol Sci. 2017;18:533.

    Article  Google Scholar 

  16. 16.

    Khanna S, Komati R, Eichenbaum DA, Hariprasad I, Ciulla TA, Hariprasad SM. Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review. BMJ Open Ophthalmol. 2019;4:e000398.

    Article  Google Scholar 

Download references

Funding

U.S. Department of Health & Human Services |NIH| National Eye Institute (NEI)—R21 EY031439-01. U.S. Department of Health & Human Services |NIH| National Institute of General Medical Sciences (NIGMS)—1 T32 GM 135141.

Author information

Affiliations

Authors

Contributions

Both authors contributed equally to the idea, preparation and writing of the manuscript (JSP and MV).

Corresponding author

Correspondence to Maribel Vazquez.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Peña, J.S., Vazquez, M. Microfluidic systems to examine Müller glia responses to anti-VEGF treatments. Eye (2021). https://doi.org/10.1038/s41433-021-01622-x

Download citation

Search

Quick links